Hyponatremia in critically ill patients

Journal of Intensive Care Medicine

Volumn 18, Issue 1, 2003, Pages 3-8

  Vachharajani, T J ^a   Zaman, F ^a   Abreo, K D ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Cerebral salt wasting syndrome; Hyponatremia; Syndrome of inappropriate antidiuretic hormone secretion

Indexed keywords

AQUAPORIN; VASOPRESSIN; SODIUM; SODIUM CHLORIDE; VASOPRESSIN DERIVATIVE;

CLINICAL PRACTICE; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HUMAN; HYPONATREMIA; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; ADULT; AGE; AGED; ANAMNESIS; CHEMISTRY; CHILD; CHRONIC DISEASE; CLASSIFICATION; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR FLUID; FLUID THERAPY; HOSPITALIZATION; HYPOVOLEMIA; INTENSIVE CARE; METHODOLOGY; PHYSIOLOGY; SCHWARTZ BARTTER SYNDROME; WATER INTOXICATION;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; AQUAPORINS; CHILD; CHRONIC DISEASE; CRITICAL CARE; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; EXTRACELLULAR FLUID; FLUID THERAPY; HUMANS; HYPONATREMIA; HYPOVOLEMIA; INAPPROPRIATE ADH SYNDROME; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; SEVERITY OF ILLNESS INDEX; SODIUM; SODIUM CHLORIDE; VASOPRESSINS; WATER INTOXICATION;

EID: 2942670318     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066602239119     Document Type: Review

References (51)

1. Baran D, Hutchuinson TA. Outcome of hyponatremia in general hospital population. Clin Nephrol. 1984;22:72-76.
2. Anderson KJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann Intern Med. 1985;102:164-168.
3. Baylis PH, Thompson CJ. Osmoregulation of vasopressin and secretion and thirst in health and disease. Clin Endocrinol. 1988;29:549-576.
4. McKenna K, Thompson CJ. Osmoregulation in clinical disorders of thirst appreciation. Clin Endocrinol 1998;49:139-152.
5. Bankir L, Bouby N, Trinh-Trang-Tan MM. The role of the kidney in the maintenance of water balance. Clin Endocrinol Metab. 1989;3:229-311.
6. Knepper MA, Rector FC Jr. Urinary concentration and dilution. In: Brenner RM, Rector FC Jr, eds. The Kidney. Philadelphia, Pa: Saunders; 1995:532-570.
7. Kokko JP, Rector FC Jr. Countercurrent multiplication system without active transport in inner medulla: new model. Kidney Int. 1972;2:214-223.
8. Neilsen S, Agre P. The aquaporin family of water channels in kidney. Kidney Int. 1995;48:1057-1068.
9. Nielsen S, Kwon TU, Christensen BM, Promeneur D, Frokiaer J, Marples D. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol. 1999;10:647-663.
10. Yamamoto T, Sasaki S. Aquaporins in the kidney: emerging new aspects. Kidney Int. 1998;54:1041-1051.
11. Knepper MA, Wade JB, Terris J, Ecelbarger CA, Marples D, Mandon B, Chou CJ, Kishore BK, Nielsen S. Renal aquaporins. Kidney Int. 1996;49:1712-1717.
12. Nonoguchi H, Sands JM, Knepper MA. Atrial natriuretic factor inhibits vasopressin stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest. 1988;82:1383-1390.
13. Mandell IN, DeFronzo RA, Robertson GL, Forrest JN. Role of plasma vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 1980;17:186-195.
14. Elalouf JM, Sari DC, deRouffignac C. Effects of glucagons and the parathyroid hormone on the loop of Henle of rat juxtamedullary nephrons. Kidney Int. 1986;29:807-813.
15. Carney S, Morgan T, Ray C, Thompson L. Effect of calcitonin on urine concentration in the rat. Am J Physiol. 1983;244:F432-F435.
16. Beck TR, Dunn MJ. The relationship of vasopressin and renal prostaglandins. Miner Electrolyte Metab. 1981;6:46-59.
17. Landenson JH, Apple FS, Koch DD. Misleading hyponatremia due to hyperlipidemia: a method dependent error. Ann Int Med. 1981;95:707-708.
18. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide induced hyponatremia: reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med. 1989;110:24-30.
19. Fichmann MP, Vorrherr H, Kleeman CR, Telfer N. Diuretic induced hyponatremia. Ann Intern Med. 1971;75:853-863.
20. Sonnenblick M, Friedlander Y, Rosin A. Diuretic induced hyponatremia. Chest. 1993;103:601-606.
21. Boykin J, deTorrnte A, Robertson GL, Erickson A, Schrier RW. Persistent plasma vasopressin levels in hypoosmolar state associated with mineralocorticoid deficiency. Miner Electrolyte Metab. 1979;2:310-315.
22. Peters JP, Welt KG, Sims EAH, Orloff J, Needham J. A salt wasting syndrome associated with cerebral disease. Trans Assoc Am Physiol. 1950;63:57-64.
23. Harrigan MR. Cerebral salt wasting. Crit Care Clin. 2001;17:125-138.
24. Weinand ME, O'Boynick PL, Goetz KL. A study of serum antidiuretic hormone and atrial natriuretic peptide levels in a series of patients with intracranial disease and hyponatremia. Neurosurgery. 1989;25:781-785.
25. Damraju SC, Rajshekhar V, Chandy MJ. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery. 1997;40:312-317.
26. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Int Med. 1985;102:164-168.
27. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106:399-403.
28. Silver SM, Kozlowki SA, Baer JE, Rogers SJ, Sterns RH. Glycine induced hyponatremia in the rat: a model of postprostatectomy syndrome. Kidney Int. 1995;47:262-268.
29. Istre O, Bjoennes J, Naess R, Hornbaek K, Forman A. Post operative cerebral edema after transcervical endometrial resection and uterine irrigation with 1.5% glycine. Lancet. 1994;314:1187-1189.
30. Smith DM, McKenna K, Thompson CJ. Hyponatremia. Clin Endocrinol. 2000;52:667-678.
31. George JM, Capen CC, Phillips AS. Biosynthesis of vasopressin in vitro and ultrastructure of bronchogenic cancer. J Clin Invest. 1972;51:141-148.
32. Robertson GL. Syndrome of inappropriate diuresis. N Engl J Med. 1989;321:538-539.
33. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med. 1978;64:613.
34. Iwasaki Y, Oiso Y, Yamanouchi K. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab. 1990;70:534-539.
35. Oelkers W. Hyponatremia and inappropriate secretion of antidiuretic hormone in patients with hypopituitarism. N Engl J Med. 1989;321:492.
36. Green HH, Harrington AR, Valtin H. On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and mineralocorticoids in revising the inhibition. J Clin Invest. 1970;49:1724-1736.
37. Riggs AT, Dysken MW, Kim SW, Opsahl JA. Review of disorders of water homeostasis in psychiatric patients. Psychosomatics. 1991;32:133-148.
38. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med. 1988;318:397-403.
39. Schrier RW, Fassett RG. Pathogenesis of sodium and water retention in cardiac failure. Renal Failure. 1998;20:773-781.
40. Schrier RW, Martin PY. Recent advances in the understanding of water metabolism in heart failure. Adv Exp Med Biol. 1998;449:415-426.
41. Xu DL, Martin PY, Ohara M, St John J, Pattison T, Meng X, Morris K, Kim JK, Schrier RW. Upregulation of aquaporin water channel expression in chronic heart failure in rats. J Clin Invest. 1997;99:1500.
42. Gross P, Reimann D, Henschkowski J. Treatment of severe hyponatremia: conventional and novel aspects. J Am Soc Nephrol. 2001;12:S10-S14.
43. Laureno R, Karp BI. Myelinosis after correction of hyponatremia. Ann Intern Med. 1997;126:57.
44. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York, NY: McGraw-Hill; 2001.
45. Adrogue H, Madias N. Hyponatremia. N Engl J Med. 2000;342;1581-1590.
46. Halperin ML, Oh MS. The Dysnatremias: Hyponatremia and Hypernatremia: Current Therapy in Nephrology and Hypertension. 4th ed. St Louis, Mo: Mosby; 1998.
47. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int. 1991;39:1274.
48. Riegger GA, Kochsiek K. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to dilated cardiomyopathy. Am J Cardiol. 1986;58:300.
49. Sterns RH. The treatment of hyponatremia: first, do no harm. Am J Med. 1990;88:557.
50. Palm C, Gross P. V2-vasopressin receptor antagonists-mechanisms of effect and clinical implications in hyponatremia. Nephrol Dial Transplant. 1999;14:2559.
51. Martinez-Castelao A. Lixivaptan (American Home Products). Curr Opin Invest Drugs. 2001;2:525-530.